Brief: Janux Therapeutics Q2 Basic EPS USD -0.42

Janux Therapeutics

08/08/2023 21:01

Aug 08 (Reuters) - Janux Therapeutics Q2 net income USD -17.508 million.
* Q2 operating income USD -20.748 million
* Q2 collaboration revenue USD 1.057 million
* Q2 operating expenses USD 21.805 million